Abstract
Merkel cell carcinoma (MCC) of the skin is a rare form of cutaneous malignancy of neuroendocrine origin with a propensity to affect predominately elderly patients in sun-exposed areas. The tumour has an extremely aggressive growth pattern with the potential to seed into the dermal lymphatics at an early stage as well as spread to nodes and distant sites. Successful outcomes can be achieved with early diagnosis and a multidisciplinary approach to management. Patients with MCC should be carefully staged to exclude distant metastatic disease. Treatment should be approached with both the primary site and the lymph nodes in mind. The primary site should be excised with clear margins, followed by postoperative radiotherapy to the primary site and affected nodes. Addition of chemotherapy to patients perceived to be at high-risk of distant recurrence (e.g. those with involved nodes) has been considered, but evidence supporting this approach is relatively scant. This treatment strategy needs to be approached with caution in the elderly because of the risk of myelosuppression. An aggressive treatment approach is warranted at the first attempt to treat MCC as treatment for recurrent disease is less likely to be successful.
Similar content being viewed by others
References
Halata Z, Grim M, Baumann KI. Friedrich Sigmund Merkel and his ‘Merkel cell’ morphology, development and physiology: review and new results. Anat Rec 2003; 271: 225–39
Szeder V, Grim M, Halata Z, et al. Neural crest origin of mammalian Merkel cells. Dev Biol 2003; 253: 258–63
Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107–10
Tang CK, Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42: 2311–21
Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999; 8(2): 153–8
Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20(2): 588–98
Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma: diagnosis and treatment. Dermatol Surg 1995; 21: 669–83
Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002; 34(5): 1780–1
Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more commonly than previously recognised in a temperate climate. Transplantation 2004; 77(4): 574–9
Engels EA, Frisch M, Goedart JJ, et al. Merkel cell carcinoma and HIV infection. Lancet 2002; 359(9305): 497–8
Sais G, Admella C, Soler T. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol 2002; 16(1): 82–3
Raaf JH, Urmacher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin: treatment of primary, recurrent and metastatic disease. Cancer 1986; 57: 178–82
Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999; 85(12): 2589–95
Pillotti S, Rilke F, Bartoli C, et al. Clinicopathological correlations of cutaneous neuroendocrine Merkel cell carcinoma. J Clin Oncol 1988; 6: 1863–73
Moll R, Lowe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected in monoclonal antibodies. Am J Pathol 1992; 140(2): 427–47
Byrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor-1 (TTF-1) in small cell carcinoma and Merkel cell carcinoma. Hum Pathol 2000; 31(1): 58–62
Su LD, Fullen DR, Lowe L, et al. CD 117 (KIT receptor) expression in Merkel cell carcinoma [abstract]. Am J Dermatopathol 2002; 24(4): 289–93
Van Gele M, Leonard JH, Van Roy N, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal arrangements in Merkel cell carcinoma. Int J Cancer 2002; 101(2): 137–45
Harnett PR, Kearsley JH, Hayward NK, et al. Loss of allelic heterozygosity on distal chromosome 1p in Merkel cell carcinoma: a marker of neural crest origins. Cancer Genet Cytogenet 1991; 54: 109–13
Leonard JH, Cook AL, Nancarrow D, et al. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma. Cancer Detect Prev 2000; 24: 620–7
Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000; 82(4): 823–6
Vortmeyer AO, Merino MJ, Boni R, et al. Genetic changes associated with Merkel cell carcinoma. Am J Clin Pathol 1998; 109(5): 565–70
Larsimont D, Verhest A. Chromosome 6 trisomy as sole anomaly in a primary Merkel cell carcinoma. Virchows Arch 1996; 428(4–5): 305–9
Leonard JH, Leonard P, Kearsley JH. Chromosomes 1, 11 and 13 are frequently involved in karyotypic abnormalities in metastatic Merkel cell carcinoma. Cancer Genet Cytogenet 1993; 67(1): 65–70
Nguyen BD, McCullough AE. Imaging of Merkel cell carcinoma. Radiographics 2002; 22(2): 367–76
Nguyen BD. Positron emission tomographic imaging of Merkel cell carcinoma. Clin Nucl Med 2002; 27(12): 922–3
Kwekkeboom DJ, Hoff AM, Lamberts SW, et al. Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualisation of Merkel cell tumours and their metastases. Arch Dermatol 1992; 128: 818–21
Durani BK, Klein A, Henze M, et al. Somatostatin analogue scintigraphy in Merkel tumours. Br J Dermatol 2003; 148(6): 1135–40
Guitera-Rovel P, Lumbroso J, Gautier-Gougis MS, et al. Indium-111 octreotide scintigraphy of Merkel cell carcinoma and their metastases. Ann Oncol 2001; 12(6): 807–11
Wong CO, Pham AN, Dworkin HJ. F-18 FDG accumulation in an Octreotide Negative Merkel Cell Tumour. Clin Positron Imaging 2000; 3(2): 71–3
Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine and neural crest tumours. Clin Nucl Med 2004; 29(2): 86–9
Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma: prognosis and management. Arch Surg 1991; 126: 1514–9
Meeuwissen JA, Bourne RG, Kearsley JH. The importance of post operative radiotherapy in the treatment of Merkel cell carcinoma. Int J Radiation Oncol Biol Phys 1995; 31: 325–31
Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997; 80: 881–5
Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy is securing locoregional control of Merkel cell carcinoma. Int J Radiation Oncol Biol Phys 1990; 19: 583–91
Poulsen M, Rischin D, Walpole E, et al. High risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study TROG 96:07. J Clin Oncol 2003; 21(23): 4371–6
Koljonen V, Bohling T, Granhroth G, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003; 29(7): 697–10
Boyle F, Pendlebury S, Bell D. Further insights in to the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiation Oncol Biol Phys 1995; 31: 315–23
Eich HT, Eich D, Staar S, et al. Role of postoperative radiotherapy in the management of Merkel cell. Am J Clin Oncol 2002; 25(1): 50–6
Coit DG. Merkel cell carcinoma. Ann Surg Oncol 2001; 8 (9 Suppl.): 99s–102s
Leonard JH, Cook AL, Van Gele M, et al. Proneural and proneuroendocrine transcription factor expression in cutaneous mechanoreceptor (Merkel) cells and Merkel cell carcinoma. Int J Cancer 2002; 101: 103–10
Ratner D, Nelson BR, Brown MD, et al. Merkel cell carcinoma. J Am Acad Derm 1993; 29: 143–56
Al Ghazal SK, Arora DS, Simpson RH, et al. Merkel cell carcinoma of the skin. Br J Plast Surg 1996; 49(7): 491–6
Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and. Arch Otolaryngol Head Neck Surg 2001; 127(2): 149–54
Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999; 229(1): 97–105
Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999; 134(4): 388–92
Ashby M, Jones DH, Tasker AD, et al. Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radiosensitive tumour. Clin Radiol 1989; 40: 85–7
Roenigk RK, Goltz RW. Merkel cell carcinoma: a problem with micrographically controlled surgery. J Dermatol Surg Oncol 1986; 12: 332–6
Rubsamen PE, Tanenbaum M, Grove AS, et al. Merkel cell carcinoma of the eyelid and periorbital tissues. Am J Ophthalmol 1992; 113: 674–80
Boyer JD, Ziltelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated. J Am Acad Derm 2002; 47(6): 885–92
Brissett AE, Olsen KD, Kasperbauer JL, et al. Merkel cell carcinoma of the head and neck: a retrospective case series. Head Neck 2002; 24(11): 982–8
Victor NS, Morton B, Smith JW. Merkel cell carcinoma: is prophylactic lymph node dissection indicated? Am Surg 1996; 62: 879–82
Hill AD, Brady MS, Coit DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999; 86(4): 518–21
Rodrigues LK, Leong SP, Kashani-Sabet M, et al. Early experience with sentinel lymph node mapping for Merkel cell carcinoma. J Am Acad Derm 2001; 45(2): 303–8
Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: 5 reports using sentinel node biopsy and review of 110 cases. Plast Reconstr Surg 2002; 110(5): 1259–65
Wasserberg N, Schachter J, Fenig E, et al. Applicability of the sentinel node technique to Merkel cell carcinoma. Dermatol Surg 2000; 26(2): 138–41
Pacella J, Ashby M, Ainslie J, et al. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumours: experience of the Peter MacCallum Cancer Institute (Melbourne Australia). Int J Radiation Oncol Biol Phys 1988; 14: 1077–84
Bourne RG, O’Rourke MG. Management of Merkel cell tumour. Aust N Z J Surg 1988; 58: 971–4
Leonard JH, Ramsay JR, Kearsley JH, et al. Radiation sensitivity of Merkel cell carcinoma cell lines. Int J Radiat Oncol Biol Phys 1995; 32: 1401–7
Tennvall J, Bjorklund A, Johansson L, et al. Merkel cell carcinoma: management of primary, recurrent and metastatic disease: a clinicopathological study of 17 patients. Eur J Surg Oncol 1989; 15: 1–9
Marks ME, Kim RY, Salter MM. Radiotherapy as an adjunct in management of Merkel cell carcinoma. Cancer 1990; 65: 60–4
Goepfert H, Remmler D, Silva E, et al. Merkel cell carcinoma (endocrine carcinoma of skin) of the head and neck. Arch Otolaryngol 1984; 110: 707–12
Kokoska ER, Kokoska MS, Collins BT, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997; 174(6): 688–93
Herbst A, Haynes HA, Nghiem P. The standard of care for Merkel cell carcinoma should include adjuvant radiation and lymph node surgery. J Am Acad Derm 2002; 46(4): 640–2
Medina Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and review of 1024 cases. Ann Surg Oncol 2001; 8(3): 204–8
Mortier L, Mirabel X, Fournier C, et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003; 139(12): 1587–90
Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991; 78: 138–42
Suntharalingam M, Rudoltz MS, Mendenhall WM, et al. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head and Neck 1995; 17: 96–101
Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroen-docrine/Merkel cell carcinoma of the skin and review of 204 cases. J Clin Oncol 2000; 18: 2493–9
Kearsley JH, Hurst T, Khoo SK. Chemosensitivity testing of primary cultures of Merkel cell cancer. Anticancer Drugs 1993; 4: 571–5
Fenig E, Brenner B, Njuguna E, et al. Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Am J Clin Oncol 2000; 23(1): 65–7
Siu LL, Shepherd FA, Murray N, et al. Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 1996; 14(3): 821–8
Davis MP, Miller EM, Rau RC, et al. The use of VP16 and cisplatin in the treatment of Merkel cell carcinoma. J Dermatol Surg Oncol 1990; 16: 276–8
Poulsen M, Rischin D, Walpole E, et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study. Int J Rad Oncology Biol Phys 2001; 51(1): 156–63
Olieman AF, Lienard D, Eggermont AM, et al. Hyperthermic isolated limb perfusion with tumour necrosis factor, interferon gamma, and melphalan for locally advanced non melanomatous skin tumours of the extremities: a multicentre study. Arch Surg 1999; 134: 303–7
Hata Y, Matsuka K, Ito O, et al. Two cases of Merkel cell carcinoma cured by intratumour injection of natural human tumour necrosis factor. Plast Reconstr Surg 1997; 99: 547–53
Bajetta E, Rimassa L, Carnaghi C, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of neuroendocrine tumours. Cancer 1998; 1998: 372–8
Zilembo N, Buzzoni R, Bajetta E, et al. Salvage treatment after r-interferon alpha-2a in advance neuroendocrine carcinoma. Acta Oncol 1993; 32: 245–50
di-Bartolomeo M, Bajetta E, Buzzoni R, et al. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumours: a study by the Italian Trials in Medical Oncology Group. Cancer 1996; 77: 402–8
Poulsen M, Harvey J. Is there a diminishing role for surgery in Merkel cell carcinoma of the skin? A review of the current management. ANZ J Surg 2002; 72(2): 142–6
Acknowledgements
There has been no assistance in the preparation of the manuscript from outside bodies and there are no conflicts of interest in any of the statements made or claimed in this paper. The support of Mayne Pharma for a study grant in 2004 to carry out a pilot study of synchronous weekly carboplatin and radiation in Merkel cell carcinoma of the skin is acknowledged.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poulsen, M. Merkel Cell Carcinoma of Skin. Drugs Aging 22, 219–229 (2005). https://doi.org/10.2165/00002512-200522030-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200522030-00004